Journal of Hematology & Oncology

Editor-in-Chief

Delong Liu, New York Medical College

Editorial Board | Instructions for authors | FAQ

Society affiliations

Journal of Hematology & Oncology is the official journal of the Chinese American Hematologist and Oncologist Network.

Articles

There has been an error retrieving the data. Please try again.

Review

Novel agents and biomarkers for acute lymphoid leukemia

Zhao Y, Huang H and Wei G Journal of Hematology & Oncology 2013, 6:40 (18 June 2013)
Case report

Rapid induction of complete molecular remission by sequential therapy with LDAC and sorafenib in FLT3-ITD-positive patients unfit for intensive treatment: two cases and review of the literature

Wolleschak D, Schalk E, Krogel C, Schnoeder TM, Luehr H, Jentsch-Ullrich K, Fischer T and Heidel FH Journal of Hematology & Oncology 2013, 6:39 (11 June 2013)
Review

Targeted therapy for HER2 positive breast cancer

Incorvati JA, Shah S, Mu Y and Lu J Journal of Hematology & Oncology 2013, 6:38 (3 June 2013)
Review

Long non-coding RNA: a new player in cancer

Zhang H, Chen Z, Wang X, Huang Z, He Z and Chen Y Journal of Hematology & Oncology 2013, 6:37 (31 May 2013)
Review

Novel agents for chronic lymphocytic leukemia

Wu M, Akinleye A and Zhu X Journal of Hematology & Oncology 2013, 6:36 (16 May 2013)
Short report

Induction of long intergenic non-coding RNA HOTAIR in lung cancer cells by type I collagen

Zhuang Y, Wang X, Nguyen HT, Zhuo Y, Cui X, Fewell C, Flemington EK and Shan B Journal of Hematology & Oncology 2013, 6:35 (13 May 2013)
Research

Activated N-Ras signaling regulates arterial-venous specification in zebrafish

Ren CG, Wang L, Jia XE, Liu YJ, Dong ZW, Jin Y, Chen Y, Deng M et al. Journal of Hematology & Oncology 2013, 6:34 (12 May 2013)
Research

Chimeric antigen receptor containing ICOS signaling domain mediates specific and efficient antitumor effect of T cells against EGFRvIII expressing glioma

Shen CJ, Yang YX, Han EQ, Cao N, Wang YF, Wang Y, Zhao YY, Zhao LM et al. Journal of Hematology & Oncology 2013, 6:33 (9 May 2013)
Short report

Azacitidine in patients with WHO-defined AML – Results of 155 patients from the Austrian Azacitidine Registry of the AGMT-Study Group

Pleyer L, Stauder R, Burgstaller S, Schreder M, Tinchon C, Pfeilstocker M, Steinkirchner S, Melchardt T et al. Journal of Hematology & Oncology 2013, 6:32 (29 April 2013)
View more articles

RSS

Comments

Erratum

Comment on: Javle et al. Journal of Hematology & Oncology 2009, 2:9

Aims & scope

Journal of Hematology & Oncology is an open access, peer-reviewed online journal that encompasses all aspects of hematology and oncology.

Latest review

Targeted therapy for HER2 positive breast cancer

Incorvati JA, Shah S, Mu Y and Lu J

Journal of Hematology & Oncology 2013, 6:38

RSS

JHO News

04 May 2013: CAHON annual reception will be on June 2, 2013 in Chicago

11 December 2012: Artificially engineered "serial killer" T cells are killing resistant leukemia cells and saving lives

18 July 2012: Melanoma drug Ipilimumab used for T cell lymphoma /Sezary syndrome

13 January 2012: Resveratrol research fraud: 145 counts of data fabrication and falsification were found in the fraud case relating to resveratrol research.

Advertisement

Submit a manuscript Register Contact us Follow
BioMed Central Support

Advertisement

Indexed by

CAS
Current contents
Embase
Google Scholar
MEDLINE
PubMed
PubMed Central
Science Citation Index Expanded
Scopus

View all

ISSN: 1756-8722